The FDA has approved the emergency use of Roche’s (OTCQX:RHHBY) cobas SARS-CoV-2 & Influenza A/B Test for use on the fully automated cobas 6800/8800 Systems.
The qualitative molecular assay simultaneously detects and differentiates the presence of the three viruses in nasal or nasopharyngeal swab samples.
https://seekingalpha.com/news/3611686-fda-oks-emergency-use-of-roche-covidminus-19-flu-combo-test
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.